Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Sep;14(3):703-8.
doi: 10.1128/iai.14.3.703-708.1976.

Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona

Susceptibility of mice treated with cyclophosphamide to lethal infection with Leptospira interrogans Serovar pomona

B Adler et al. Infect Immun. 1976 Sep.

Abstract

Mice not normally susceptible to infection with Leptospira interrogans serovar pomona were rendered susceptible to lethal infections by treatment with a single dose of 300 mg of cyclophosphamide (Cy) per kg administered optimally from 4 days before to 1 day after infection. Cy-treated mice with either passively or actively acquired antibody were protected from death. Blood levels of leptospires in infected untreated and in Cy-treated mice remained similar until 2 days after infection, when untreated mice cleared the leptospires. Soon afterwards, opsonizing and agglutinating antibody appeared. Cy-treated mice given spleen cells from other normal or specifically immune mice were protected from infection. An important factor in the natural resistance of mice to leptospiral infection appears to be their capacity to produce circulating antibody within 48 to 72 h. Applications are suggested for this animal model in vaccination and protection studies.

PubMed Disclaimer

References

    1. Cancer Res. 1965 Jun;25:745-51 - PubMed
    1. Am J Vet Res. 1964 May;25:830-5 - PubMed
    1. J Infect Dis. 1974 Dec;130(6):634-41 - PubMed
    1. Ann Immunol (Paris). 1974 Mar-Apr;125(3):415-26 - PubMed
    1. J Immunol. 1973 Jan;110(1):277-82 - PubMed

LinkOut - more resources